| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | TCEA1 CALB1 ANPEP POLA1 BAZ1B DNAJC21 DPP3 TRIM14 TRIM52 RNF14 RNPEP TLL2 RECQL4 PAM ZMYM4 | 4.05e-05 | 891 | 101 | 15 | GO:0008270 |
| GeneOntologyBiologicalProcess | regulation of nucleus organization | 2.37e-05 | 2 | 101 | 2 | GO:1903353 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PDE3A SYNE1 FRMD7 OBSL1 BAZ1B RICTOR TWF2 CUL7 XRCC5 TWF1 USP10 NCAPG VILL NFE2L1 RECQL4 DIAPH1 PAM IQCJ-SCHIP1 PICK1 | 2.43e-05 | 1342 | 101 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | DNA strand elongation involved in DNA replication | 4.97e-05 | 15 | 101 | 3 | GO:0006271 | |
| GeneOntologyBiologicalProcess | glial cell projection elongation | 7.10e-05 | 3 | 101 | 2 | GO:0106091 | |
| GeneOntologyBiologicalProcess | mitotic DNA replication | 7.37e-05 | 17 | 101 | 3 | GO:1902969 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | FRMD7 BAZ1B TWF2 XRCC5 TWF1 USP10 PTPRG VILL RECQL4 CST2 DIAPH1 IQCJ-SCHIP1 PICK1 PCSK9 | 8.00e-05 | 864 | 101 | 14 | GO:0051129 |
| GeneOntologyBiologicalProcess | lagging strand elongation | 1.42e-04 | 4 | 101 | 2 | GO:0006273 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 2.25e-04 | 421 | 101 | 9 | GO:0010639 | |
| GeneOntologyBiologicalProcess | mitotic DNA replication initiation | 2.35e-04 | 5 | 101 | 2 | GO:1902975 | |
| GeneOntologyBiologicalProcess | nuclear cell cycle DNA replication initiation | 2.35e-04 | 5 | 101 | 2 | GO:1902315 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication initiation | 2.35e-04 | 5 | 101 | 2 | GO:1902292 | |
| GeneOntologyCellularComponent | alpha DNA polymerase:primase complex | 2.29e-04 | 5 | 101 | 2 | GO:0005658 | |
| GeneOntologyCellularComponent | 3M complex | 2.29e-04 | 5 | 101 | 2 | GO:1990393 | |
| Domain | ARM-like | 1.46e-05 | 270 | 100 | 9 | IPR011989 | |
| Domain | Twinfilin | 2.84e-05 | 2 | 100 | 2 | IPR028458 | |
| Domain | OKL38_fam | 2.84e-05 | 2 | 100 | 2 | IPR029731 | |
| Domain | EGF_3 | 3.84e-05 | 235 | 100 | 8 | PS50026 | |
| Domain | EGF-like_dom | 5.77e-05 | 249 | 100 | 8 | IPR000742 | |
| Domain | EGF_1 | 6.82e-05 | 255 | 100 | 8 | PS00022 | |
| Domain | EGF_2 | 8.92e-05 | 265 | 100 | 8 | PS01186 | |
| Domain | EGF | 2.71e-04 | 235 | 100 | 7 | SM00181 | |
| Domain | - | 2.78e-04 | 24 | 100 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 2.78e-04 | 24 | 100 | 3 | IPR029006 | |
| Domain | E2F_CC-MB | 4.20e-04 | 6 | 100 | 2 | IPR032198 | |
| Domain | E2F_CC-MB | 4.20e-04 | 6 | 100 | 2 | PF16421 | |
| Domain | ARM-type_fold | 4.74e-04 | 339 | 100 | 8 | IPR016024 | |
| Domain | EGF_CA | 5.03e-04 | 122 | 100 | 5 | SM00179 | |
| Domain | EGF-like_CS | 5.09e-04 | 261 | 100 | 7 | IPR013032 | |
| Domain | EGF-like_Ca-bd_dom | 5.41e-04 | 124 | 100 | 5 | IPR001881 | |
| Domain | E2F | 7.78e-04 | 8 | 100 | 2 | IPR015633 | |
| Domain | LAM_G_DOMAIN | 1.10e-03 | 38 | 100 | 3 | PS50025 | |
| Domain | - | 1.24e-03 | 222 | 100 | 6 | 1.25.10.10 | |
| Domain | ADF | 1.24e-03 | 10 | 100 | 2 | SM00102 | |
| Domain | Cofilin_ADF | 1.24e-03 | 10 | 100 | 2 | PF00241 | |
| Domain | ADF_H | 1.24e-03 | 10 | 100 | 2 | PS51263 | |
| Domain | ADF-H | 1.24e-03 | 10 | 100 | 2 | IPR002108 | |
| Domain | Laminin_G_2 | 1.27e-03 | 40 | 100 | 3 | PF02210 | |
| Domain | E2F_TDP | 1.51e-03 | 11 | 100 | 2 | PF02319 | |
| Domain | E2F_TDP | 1.51e-03 | 11 | 100 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 1.51e-03 | 11 | 100 | 2 | IPR003316 | |
| Domain | LamG | 1.68e-03 | 44 | 100 | 3 | SM00282 | |
| Domain | Peptidase_M1 | 1.81e-03 | 12 | 100 | 2 | IPR001930 | |
| Domain | Peptidase_M1_N | 2.13e-03 | 13 | 100 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 2.13e-03 | 13 | 100 | 2 | PF01433 | |
| Domain | HEAT | 2.16e-03 | 48 | 100 | 3 | PF02985 | |
| Domain | HEAT | 3.71e-03 | 58 | 100 | 3 | IPR000357 | |
| Domain | Laminin_G | 3.71e-03 | 58 | 100 | 3 | IPR001791 | |
| Domain | EGF | 4.70e-03 | 126 | 100 | 4 | PF00008 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX OBSL1 BAZ1B MCM3 E2F2 E2F3 TWF2 ITPRID2 CUL7 ZNF644 DIAPH1 ZMYM4 GAB1 | 1.91e-08 | 588 | 102 | 13 | 38580884 |
| Pubmed | Transcriptional regulation of fibrillin-2 gene by E2F family members in chondrocyte differentiation. | 2.44e-07 | 5 | 102 | 3 | 19142862 | |
| Pubmed | IPO7 SYNE1 POLR1C BMS1 OBSL1 BAZ1B DNAJC21 RICTOR ITPRID2 XRCC5 GTF3C3 USP10 NCAPG NSFL1C ZNF644 NEURL4 VPS13B GAB1 | 3.07e-07 | 1487 | 102 | 18 | 33957083 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PRPF31 NSD2 POLR1C BMS1 BAZ1B DNAJC21 YTHDC2 CUL7 XRCC5 GTF3C3 USP10 NEURL4 WDR24 | 3.61e-07 | 759 | 102 | 13 | 35915203 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PRPF31 IPO7 NSD2 POLA1 ACLY SYNE1 BMS1 BAZ1B MCM3 YTHDC2 XRCC5 TRIM14 GTF3C3 USP10 NCAPG RNPEP DIAPH1 | 8.35e-07 | 1425 | 102 | 17 | 30948266 |
| Pubmed | TCEA1 PRPF31 IPO7 NSD2 POLA1 POLR1C BAZ1B MCM3 XRCC5 GTF3C3 USP10 NCAPG RNPEP DIAPH1 | 1.61e-06 | 1014 | 102 | 14 | 32416067 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PRPF31 SETX IPO7 NSD2 POLA1 BAZ1B E2F3 XRCC5 GTF3C3 ZNF644 ZMYM4 | 1.80e-06 | 608 | 102 | 11 | 36089195 |
| Pubmed | Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination. | 2.03e-06 | 9 | 102 | 3 | 24322982 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 SETX IPO7 POLA1 ACLY POLR1C BMS1 BAZ1B MCM3 RICTOR XRCC5 GTF3C3 NCAPG NSFL1C RECQL4 DIAPH1 | 2.04e-06 | 1353 | 102 | 16 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCEA1 ACLY BAZ1B MCM3 RICTOR YTHDC2 ITPRID2 LIG1 USP10 NSFL1C ZNF644 ZMYM4 | 2.94e-06 | 774 | 102 | 12 | 15302935 |
| Pubmed | 3.01e-06 | 210 | 102 | 7 | 16537572 | ||
| Pubmed | IPO7 NSD2 POLA1 ACLY BMS1 BAZ1B YTHDC2 CUL7 XRCC5 GTF3C3 RNPEP | 3.57e-06 | 653 | 102 | 11 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPF31 IPO7 ACLY POLR1C BMS1 BAZ1B DNAJC21 MCM3 YTHDC2 ITPRID2 XRCC5 TRIM14 GTF3C3 TWF1 USP10 | 3.96e-06 | 1257 | 102 | 15 | 36526897 |
| Pubmed | 4.47e-06 | 223 | 102 | 7 | 33731348 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TCEA1 PDE3A IPO7 POLA1 ACLY POLR1C MCM3 UNC13D TWF2 DPP3 XRCC5 TWF1 LIG1 NCAPG NSFL1C DIAPH1 | 5.16e-06 | 1455 | 102 | 16 | 22863883 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRPF31 IPO7 POLA1 POLR1C BMS1 YTHDC2 DPP3 USP10 SPATA2L NSFL1C NEURL4 ZMYM4 WDR24 | 7.89e-06 | 1005 | 102 | 13 | 19615732 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PRPF31 SETX ACLY BMS1 OBSL1 CUL7 GTF3C3 NCAPG ZNF644 RECQL4 CCDC15 ZMYM4 | 8.24e-06 | 857 | 102 | 12 | 25609649 |
| Pubmed | Cloning, expression and characterization of an A6-related protein. | 8.52e-06 | 2 | 102 | 2 | 10406962 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34597859 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18837697 | ||
| Pubmed | Twinfilin 2a regulates platelet reactivity and turnover in mice. | 8.52e-06 | 2 | 102 | 2 | 28743718 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30980518 | ||
| Pubmed | Calbindin and S100 protein expression in the developing inner ear in mice. | 8.52e-06 | 2 | 102 | 2 | 19226521 | |
| Pubmed | Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis. | 8.52e-06 | 2 | 102 | 2 | 23603666 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11870207 | ||
| Pubmed | Contrasting roles of E2F2 and E2F3 in cardiac neovascularization. | 8.52e-06 | 2 | 102 | 2 | 23799044 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12807912 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30566865 | ||
| Pubmed | PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19. | 8.52e-06 | 2 | 102 | 2 | 39053672 | |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 1.02e-05 | 468 | 102 | 9 | 36042349 | |
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 28803780 | ||
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 21185283 | ||
| Pubmed | TCEA1 AMER1 SETX BAZ1B UNC13D RICTOR ALS2 PRAMEF18 VILL NFE2L1 DIAPH1 VPS13B SERTAD3 | 1.75e-05 | 1084 | 102 | 13 | 11544199 | |
| Pubmed | 2.52e-05 | 660 | 102 | 10 | 32780723 | ||
| Pubmed | A rare cause of syndromic short stature: 3M syndrome in three families. | 2.55e-05 | 3 | 102 | 2 | 33258289 | |
| Pubmed | Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. | 2.55e-05 | 3 | 102 | 2 | 20404092 | |
| Pubmed | RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complex. | 2.55e-05 | 3 | 102 | 2 | 24942867 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20301654 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 35069527 | ||
| Pubmed | Transcription factor compensation during mammary gland development in E2F knockout mice. | 2.55e-05 | 3 | 102 | 2 | 29617434 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23205607 | ||
| Pubmed | The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. | 2.55e-05 | 3 | 102 | 2 | 22156540 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24934442 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10673353 | ||
| Pubmed | Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors. | 2.55e-05 | 3 | 102 | 2 | 21245101 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23500679 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 21737058 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18594513 | ||
| Pubmed | Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. | 2.55e-05 | 3 | 102 | 2 | 23018678 | |
| Pubmed | The E2F1-3 transcription factors are essential for cellular proliferation. | 2.55e-05 | 3 | 102 | 2 | 11719808 | |
| Pubmed | An E2F1/MiR-17-92 Negative Feedback Loop mediates proliferation of Mouse Palatal Mesenchymal Cells. | 2.55e-05 | 3 | 102 | 2 | 28698574 | |
| Pubmed | 2.66e-05 | 529 | 102 | 9 | 14621295 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.02e-05 | 202 | 102 | 6 | 33005030 | |
| Pubmed | 3.62e-05 | 22 | 102 | 3 | 27146480 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 4.22e-05 | 316 | 102 | 7 | 31665637 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 IPO7 ACLY SYNE1 OBSL1 BAZ1B MCM3 YTHDC2 ITPRID2 CUL7 XRCC5 NEURL4 | 4.72e-05 | 1024 | 102 | 12 | 24711643 |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26311161 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26396186 | ||
| Pubmed | Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. | 5.09e-05 | 4 | 102 | 2 | 8657141 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21115501 | ||
| Pubmed | Myc requires distinct E2F activities to induce S phase and apoptosis. | 5.09e-05 | 4 | 102 | 2 | 11511364 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 25088905 | ||
| Pubmed | EAPP, a novel E2F binding protein that modulates E2F-dependent transcription. | 5.09e-05 | 4 | 102 | 2 | 15716352 | |
| Pubmed | Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. | 5.09e-05 | 4 | 102 | 2 | 12065245 | |
| Pubmed | HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors. | 5.09e-05 | 4 | 102 | 2 | 24362522 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 36607545 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17167174 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 24793695 | ||
| Pubmed | The subcellular localization of E2F-4 is cell-cycle dependent. | 5.09e-05 | 4 | 102 | 2 | 9144196 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17135249 | ||
| Pubmed | E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. | 5.09e-05 | 4 | 102 | 2 | 19015245 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12915315 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9891995 | ||
| Pubmed | Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2. | 5.09e-05 | 4 | 102 | 2 | 17855529 | |
| Pubmed | E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. | 5.09e-05 | 4 | 102 | 2 | 20016602 | |
| Pubmed | 5.76e-05 | 332 | 102 | 7 | 25693804 | ||
| Pubmed | IPO7 NSD2 BMS1 PPP2R3B RICTOR ITPRID2 CUL7 NCAPG PTPRG CSPG5 NEURL4 GAB1 | 5.95e-05 | 1049 | 102 | 12 | 27880917 | |
| Pubmed | 7.47e-05 | 469 | 102 | 8 | 27634302 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 7.66e-05 | 754 | 102 | 10 | 33060197 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 7.88e-05 | 349 | 102 | 7 | 25665578 | |
| Pubmed | Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. | 8.47e-05 | 5 | 102 | 2 | 17608565 | |
| Pubmed | Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. | 8.47e-05 | 5 | 102 | 2 | 26192440 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 17008321 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 15574337 | ||
| Pubmed | Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. | 8.47e-05 | 5 | 102 | 2 | 22521878 | |
| Pubmed | Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis. | 8.47e-05 | 5 | 102 | 2 | 24276244 | |
| Pubmed | The retinoblastoma tumor suppressor regulates a xenobiotic detoxification pathway. | 8.47e-05 | 5 | 102 | 2 | 22022495 | |
| Pubmed | Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. | 8.47e-05 | 5 | 102 | 2 | 8846921 | |
| Pubmed | Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice. | 8.47e-05 | 5 | 102 | 2 | 34193976 | |
| Pubmed | Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. | 8.47e-05 | 5 | 102 | 2 | 17881568 | |
| Pubmed | Cooperative assembly of a protein-DNA filament for nonhomologous end joining. | 8.47e-05 | 5 | 102 | 2 | 23620595 | |
| Pubmed | A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. | 8.47e-05 | 5 | 102 | 2 | 19749980 | |
| Pubmed | Division and apoptosis of E2f-deficient retinal progenitors. | 8.47e-05 | 5 | 102 | 2 | 20016601 | |
| Pubmed | 9.39e-05 | 30 | 102 | 3 | 34780058 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 9.55e-05 | 486 | 102 | 8 | 30940648 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.03e-04 | 157 | 102 | 5 | 30686591 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.08e-04 | 495 | 102 | 8 | 27705803 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.12e-04 | 256 | 102 | 6 | 32698014 | |
| Pubmed | 1.12e-04 | 638 | 102 | 9 | 33239621 | ||
| Pubmed | 1.14e-04 | 32 | 102 | 3 | 33288908 | ||
| Interaction | HECTD1 interactions | PRPF31 IPO7 NSD2 GPATCH1 POLR1C BMS1 OBSL1 BAZ1B DNAJC21 YTHDC2 CUL7 XRCC5 GTF3C3 USP10 NCAPG RECQL4 TTLL1 NEURL4 WDR24 | 3.17e-07 | 984 | 100 | 19 | int:HECTD1 |
| Interaction | PARP1 interactions | PRPF31 NSD2 POLA1 POLR1C BMS1 OBSL1 BAZ1B MCM3 RICTOR E2F3 YTHDC2 ITPRID2 CUL7 XRCC5 TRIM14 GTF3C3 LIG1 USP10 NCAPG ZNF644 RECQL4 ZMYM4 | 3.80e-07 | 1316 | 100 | 22 | int:PARP1 |
| Interaction | POLR2A interactions | TCEA1 SETX CALB1 NSD2 POLR1C OBSL1 BAZ1B MCM3 E2F3 CUL7 XRCC5 GTF3C3 RECQL4 NEURL4 | 4.06e-07 | 536 | 100 | 14 | int:POLR2A |
| Interaction | TRIM52 interactions | 4.47e-06 | 133 | 100 | 7 | int:TRIM52 | |
| Interaction | PCNA interactions | NSD2 POLA1 ACLY OBSL1 BAZ1B E2F3 GCK CUL7 XRCC5 LIG1 USP10 RECQL4 | 6.51e-06 | 497 | 100 | 12 | int:PCNA |
| Interaction | TFDP3 interactions | 2.98e-05 | 36 | 100 | 4 | int:TFDP3 | |
| Interaction | TRIM28 interactions | PRPF31 AMER1 IPO7 NSD2 POLA1 ACLY POLR1C OBSL1 BAZ1B MCM3 RICTOR E2F3 YTHDC2 CUL7 XRCC5 LIG1 NCAPG ZNF644 RECQL4 ZMYM4 | 3.16e-05 | 1474 | 100 | 20 | int:TRIM28 |
| Interaction | PNMA2 interactions | 3.59e-05 | 251 | 100 | 8 | int:PNMA2 | |
| Interaction | CDC6 interactions | 3.74e-05 | 125 | 100 | 6 | int:CDC6 | |
| Interaction | IFI16 interactions | PRPF31 IPO7 NSD2 ACLY SYNE1 POLR1C BMS1 BAZ1B YTHDC2 ITPRID2 XRCC5 GTF3C3 USP10 | 5.18e-05 | 714 | 100 | 13 | int:IFI16 |
| Interaction | RUVBL2 interactions | PRPF31 POLR1C OBSL1 CRTAC1 RICTOR RDM1 CUL7 XRCC5 LIG1 USP10 NCAPG RECQL4 | 5.40e-05 | 616 | 100 | 12 | int:RUVBL2 |
| Interaction | NUP43 interactions | SETX NSD2 POLA1 GPATCH1 BMS1 RICTOR ITPRID2 CUL7 ZNF644 GUCY2D RECQL4 ZMYM4 | 6.21e-05 | 625 | 100 | 12 | int:NUP43 |
| Interaction | FBL interactions | PRPF31 IPO7 POLR1C BMS1 OBSL1 BAZ1B YTHDC2 CUL7 GTF3C3 ZNF644 RECQL4 ZMYM4 | 7.67e-05 | 639 | 100 | 12 | int:FBL |
| Interaction | CDC5L interactions | STK36 SETX IPO7 SYNE1 GPATCH1 BMS1 OBSL1 MCM3 RICTOR CUL7 TWF1 USP10 RECQL4 DIAPH1 | 8.19e-05 | 855 | 100 | 14 | int:CDC5L |
| Interaction | CBX3 interactions | AMER1 NSD2 ACLY OBSL1 BAZ1B CUL7 TRIM14 LIG1 ZNF644 RECQL4 DIAPH1 ZMYM4 | 8.50e-05 | 646 | 100 | 12 | int:CBX3 |
| Interaction | ZNF764 interactions | 1.00e-04 | 93 | 100 | 5 | int:ZNF764 | |
| Interaction | CENPA interactions | 1.08e-04 | 377 | 100 | 9 | int:CENPA | |
| Interaction | DNAJC9 interactions | 1.14e-04 | 296 | 100 | 8 | int:DNAJC9 | |
| Interaction | RUVBL1 interactions | PRPF31 ACLY POLR1C OBSL1 CRTAC1 RICTOR CUL7 USP10 NCAPG RECQL4 VAV1 | 1.32e-04 | 575 | 100 | 11 | int:RUVBL1 |
| Interaction | WDR75 interactions | 1.70e-04 | 104 | 100 | 5 | int:WDR75 | |
| Interaction | TOP1 interactions | PRPF31 NSD2 POLA1 OBSL1 BAZ1B MCM3 CUL7 XRCC5 GTF3C3 LIG1 DIAPH1 IL7R | 1.71e-04 | 696 | 100 | 12 | int:TOP1 |
| Interaction | POLE3 interactions | 1.85e-04 | 106 | 100 | 5 | int:POLE3 | |
| Interaction | XRCC6 interactions | NSD2 GPATCH1 BMS1 OBSL1 BAZ1B RICTOR YTHDC2 CUL7 XRCC5 USP10 NSFL1C RECQL4 DIAPH1 VAV1 | 1.93e-04 | 928 | 100 | 14 | int:XRCC6 |
| Interaction | PRMT1 interactions | PRPF31 IPO7 ACLY POLR1C BMS1 OBSL1 MCM3 YTHDC2 CUL7 XRCC5 TWF1 USP10 NCAPG RECQL4 | 1.95e-04 | 929 | 100 | 14 | int:PRMT1 |
| Interaction | PTEN interactions | STK36 SETX IPO7 NSD2 MCM3 YTHDC2 ITPRID2 XRCC5 GTF3C3 USP10 FBN2 NSFL1C PICK1 OSGIN1 | 1.95e-04 | 929 | 100 | 14 | int:PTEN |
| Interaction | NCAPH2 interactions | 1.98e-04 | 169 | 100 | 6 | int:NCAPH2 | |
| Interaction | NSUN5P1 interactions | 2.11e-04 | 59 | 100 | 4 | int:NSUN5P1 | |
| Interaction | PCGF6 interactions | 2.11e-04 | 171 | 100 | 6 | int:PCGF6 | |
| Interaction | SMARCA5 interactions | 2.22e-04 | 415 | 100 | 9 | int:SMARCA5 | |
| Interaction | HMGA1 interactions | 2.39e-04 | 419 | 100 | 9 | int:HMGA1 | |
| Interaction | EED interactions | TCEA1 SETX IPO7 NSD2 ACLY BAZ1B MCM3 RICTOR TWF2 CUL7 XRCC5 GTF3C3 LIG1 USP10 RNPEP VILL GUCY2D VAV1 | 2.45e-04 | 1445 | 100 | 18 | int:EED |
| GeneFamily | E2F transcription factors | 3.51e-04 | 8 | 65 | 2 | 982 | |
| GeneFamily | Cadherin related | 1.67e-03 | 17 | 65 | 2 | 24 | |
| GeneFamily | Aminopeptidases|CD molecules | 1.67e-03 | 17 | 65 | 2 | 104 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.31e-05 | 199 | 102 | 7 | M3912 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | PRPF31 IPO7 NSD2 POLA1 ACLY BAZ1B DNAJC21 MCM3 E2F2 E2F3 DPP3 LIG1 NCAPG RNPEP RECQL4 DIAPH1 IL7R | 1.94e-05 | 1363 | 102 | 17 | M45782 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | TCEA1 IPO7 NSD2 ACLY POLR1C MCM3 XRCC5 GTF3C3 LIG1 USP10 NCAPG | 2.68e-05 | 612 | 102 | 11 | M4772 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 6.62e-05 | 376 | 99 | 9 | GSM538418_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 1.06e-04 | 400 | 99 | 9 | GSM538358_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 1.08e-04 | 401 | 99 | 9 | GSM399450_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | SETX NSD2 POLA1 BMS1 DNAJC21 MCM3 ALS2 YTHDC2 XRCC5 GTF3C3 LIG1 NCAPG DIAPH1 | 1.14e-04 | 822 | 99 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 1.25e-04 | 409 | 99 | 9 | GSM399452_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3 | 1.35e-04 | 413 | 99 | 9 | GSM791149_500 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.94e-09 | 180 | 102 | 8 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-08 | 195 | 102 | 8 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-08 | 199 | 102 | 8 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-07 | 169 | 102 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 179 | 102 | 7 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-07 | 194 | 102 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 3.25e-07 | 194 | 102 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.25e-07 | 194 | 102 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-07 | 194 | 102 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-07 | 194 | 102 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-07 | 194 | 102 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.36e-07 | 195 | 102 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.36e-07 | 195 | 102 | 7 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.48e-07 | 196 | 102 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.86e-07 | 199 | 102 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 3.86e-07 | 199 | 102 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.86e-07 | 199 | 102 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 3.99e-07 | 200 | 102 | 7 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-07 | 200 | 102 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 167 | 102 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-06 | 169 | 102 | 6 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 169 | 102 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.84e-06 | 172 | 102 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-06 | 179 | 102 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 183 | 102 | 6 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 187 | 102 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 4.74e-06 | 188 | 102 | 6 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 188 | 102 | 6 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-06 | 191 | 102 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-06 | 191 | 102 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 5.68e-06 | 194 | 102 | 6 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.68e-06 | 194 | 102 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-06 | 195 | 102 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.85e-06 | 195 | 102 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-06 | 195 | 102 | 6 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 6.02e-06 | 196 | 102 | 6 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 197 | 102 | 6 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.38e-06 | 198 | 102 | 6 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 6.38e-06 | 198 | 102 | 6 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.38e-06 | 198 | 102 | 6 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.57e-06 | 199 | 102 | 6 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.57e-06 | 199 | 102 | 6 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.57e-06 | 199 | 102 | 6 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.57e-06 | 199 | 102 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.57e-06 | 199 | 102 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 6.57e-06 | 199 | 102 | 6 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-06 | 199 | 102 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 6.57e-06 | 199 | 102 | 6 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 6.57e-06 | 199 | 102 | 6 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.57e-06 | 199 | 102 | 6 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 6.76e-06 | 200 | 102 | 6 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 6.76e-06 | 200 | 102 | 6 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.76e-06 | 200 | 102 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.76e-06 | 200 | 102 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | P07-Hematopoietic|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-05 | 138 | 102 | 5 | fb8038393c2b88eb29bd23574c0c6178644900be | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 159 | 102 | 5 | 95128a2367ff2a639b21913c0350924c174faef8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 164 | 102 | 5 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 164 | 102 | 5 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 165 | 102 | 5 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 169 | 102 | 5 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 172 | 102 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 4.89e-05 | 173 | 102 | 5 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | BL-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.89e-05 | 173 | 102 | 5 | 90700a876d997f7c0f7b3899dffcda7fdafee547 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 174 | 102 | 5 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.02e-05 | 174 | 102 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 174 | 102 | 5 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.30e-05 | 176 | 102 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.45e-05 | 177 | 102 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.45e-05 | 177 | 102 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 178 | 102 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 178 | 102 | 5 | 79823d13652177de852c2acce9159049241f1d86 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 179 | 102 | 5 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.06e-05 | 181 | 102 | 5 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 6.22e-05 | 182 | 102 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.38e-05 | 183 | 102 | 5 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 184 | 102 | 5 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 184 | 102 | 5 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 184 | 102 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-05 | 186 | 102 | 5 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 187 | 102 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 7.43e-05 | 189 | 102 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 189 | 102 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 7.62e-05 | 190 | 102 | 5 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 191 | 102 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 191 | 102 | 5 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.81e-05 | 191 | 102 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 191 | 102 | 5 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-05 | 191 | 102 | 5 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| Computational | Neighborhood of PRKDC | 1.14e-06 | 191 | 61 | 9 | MORF_PRKDC | |
| Computational | Neighborhood of BUB3 | 2.36e-05 | 277 | 61 | 9 | MORF_BUB3 | |
| Computational | Neighborhood of XRCC5 | 5.02e-05 | 235 | 61 | 8 | MORF_XRCC5 | |
| Computational | Neighborhood of RAD23A | 1.38e-04 | 348 | 61 | 9 | MORF_RAD23A | |
| Computational | Neighborhood of HDAC2 | 1.71e-04 | 280 | 61 | 8 | MORF_HDAC2 | |
| Computational | Genes in the cancer module 198. | 2.92e-04 | 303 | 61 | 8 | MODULE_198 | |
| Computational | Neighborhood of GNB1 | 3.05e-04 | 305 | 61 | 8 | MORF_GNB1 | |
| Computational | Neighborhood of PPP1CC | 3.41e-04 | 166 | 61 | 6 | MORF_PPP1CC | |
| Computational | TFs and nuclear. | 3.67e-04 | 237 | 61 | 7 | MODULE_252 | |
| Computational | Neighborhood of EIF3S2 | 4.59e-04 | 246 | 61 | 7 | MORF_EIF3S2 | |
| Computational | Genes in the cancer module 318. | 5.15e-04 | 28 | 61 | 3 | MODULE_318 | |
| Computational | Neighborhood of DNMT1 | 5.33e-04 | 118 | 61 | 5 | MORF_DNMT1 | |
| Computational | Response to DNA damage. | 6.42e-04 | 187 | 61 | 6 | MODULE_244 | |
| Computational | Neighborhood of CDC16 | 8.45e-04 | 75 | 61 | 4 | MORF_CDC16 | |
| Computational | Neighborhood of AATF | 1.15e-03 | 209 | 61 | 6 | MORF_AATF | |
| Computational | Genes in the cancer module 98. | 1.60e-03 | 393 | 61 | 8 | MODULE_98 | |
| Computational | DNA replication. | 1.83e-03 | 43 | 61 | 3 | MODULE_158 | |
| Computational | Genes in the cancer module 125. | 1.95e-03 | 44 | 61 | 3 | MODULE_125 | |
| Computational | Metal ion (zinc) binding. | 2.08e-03 | 45 | 61 | 3 | MODULE_280 | |
| Computational | DNA damage response. | 2.22e-03 | 46 | 61 | 3 | MODULE_403 | |
| Computational | Neighborhood of RRM1 | 2.64e-03 | 102 | 61 | 4 | MORF_RRM1 | |
| Disease | 3-M syndrome (is_implicated_in) | 3.20e-05 | 3 | 97 | 2 | DOID:0060241 (is_implicated_in) | |
| Disease | 3-M syndrome | 3.20e-05 | 3 | 97 | 2 | cv:C1848862 | |
| Disease | Ataxias, Hereditary | 2.96e-04 | 8 | 97 | 2 | C0004138 | |
| Disease | response to TNF antagonist | 7.56e-04 | 54 | 97 | 3 | EFO_0004653 | |
| Disease | ascending aortic diameter | 1.20e-03 | 140 | 97 | 4 | EFO_0021787 | |
| Disease | Amyotrophic lateral sclerosis | 1.41e-03 | 17 | 97 | 2 | cv:C0002736 | |
| Disease | food allergy measurement, parental genotype effect measurement | 1.58e-03 | 18 | 97 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | Nonsyndromic genetic hearing loss | 2.03e-03 | 76 | 97 | 3 | cv:C5680182 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.23e-03 | 166 | 97 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | blood pressure | 2.37e-03 | 22 | 97 | 2 | EFO_0004325 | |
| Disease | susceptibility to childhood ear infection measurement | 2.48e-03 | 171 | 97 | 4 | EFO_0007904 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEEYQELQLDGFDNE | 96 | P23470 | |
| EGDITGFLAESEEDY | 431 | Q2TAA5 | |
| EEYNGVIEEFLATGE | 261 | Q9H4A4 | |
| DFQLEDGYDFLEVTG | 246 | Q7Z408 | |
| DIIDIDYFEGLDGEG | 206 | O95196 | |
| GVLLSEDDTIYEGEF | 1211 | Q96Q42 | |
| TLLQDEIAEDYGELG | 661 | Q9UIG0 | |
| GAEESLGLLDDYLEV | 26 | P18848 | |
| SYGLDQLESEEGQED | 601 | Q86TY3 | |
| EEEVLDQGDFYSLLS | 381 | P19021 | |
| DEDLAASLEAFELGY | 831 | Q5JTC6 | |
| EFEGELADDLAGFYR | 181 | P15144 | |
| NEKLGLDAGDEYEDE | 171 | P11912 | |
| LDAGDEYEDENLYEG | 176 | P11912 | |
| DEQGEEDSYDLKGRL | 366 | O60610 | |
| DEELYGDFEDLETGD | 776 | Q14692 | |
| ETLDLEEAEGAVGYQ | 531 | Q14494 | |
| DLDGDGALSMFELEY | 401 | Q9Y5P8 | |
| GDSGELDEFLLEYDR | 261 | P35557 | |
| GQEEEGYLSDFSLEE | 261 | Q8NG50 | |
| GLEDVQVYDGEDAVF | 621 | O75147 | |
| LGETEDLLSFEAYEL | 426 | A6NCF5 | |
| LQLEDLDGFEGYSLS | 31 | O75951 | |
| LGGEEQRYLLEAAEE | 251 | Q02846 | |
| GDKQVEYLDLDLDSG | 621 | Q13480 | |
| SGSLQLDEEDEDAYF | 681 | Q6ZUT3 | |
| AELLNYASEDDEGEL | 21 | Q8IVV2 | |
| DGLFGGLQDFDELYD | 596 | Q8N6G6 | |
| FGVGALEEEDDDIYA | 286 | Q9BRR8 | |
| QEDEDGDYEELVLAL | 31 | Q8NBP7 | |
| AQDDDSGLDGELQYF | 1056 | Q9NYQ8 | |
| DDIDEDGQEYLEILA | 906 | O95373 | |
| EFYEQGDEEASLGLP | 971 | Q14432 | |
| LDDYEEISAGDEGEF | 386 | Q14999 | |
| EDGAEGYSDLFRENA | 411 | O75037 | |
| ETLALTYGFLEEEDL | 296 | Q5VWM3 | |
| GEFVNEYVGELIDEE | 1086 | O96028 | |
| GLLQYSEEDCAFEEE | 111 | O95750 | |
| LLYLDDGGDCDFLEL | 66 | Q9P2S2 | |
| EIFGFEGADAEDVIY | 526 | Q9NY33 | |
| QNGDLEDAELDDYSF | 26 | P16871 | |
| YEGNLLEAGLELERD | 131 | Q5XXA6 | |
| GFDGEYQDDSLDLLR | 76 | Q5F1R6 | |
| IALASFYEDGGDEDI | 36 | Q9UNZ2 | |
| EEILYNLGFGRDEPD | 181 | P28290 | |
| FLLESEEDGQGYLED | 611 | Q6R327 | |
| EEDGQGYLEDLVKDI | 616 | Q6R327 | |
| LGDEDEEIDGDTNKY | 816 | P09884 | |
| DEGLNGQTEYFLTDE | 1961 | Q6V1P9 | |
| QRDYLDFLDDEEDQG | 16 | P25205 | |
| VDQDLEYLSEGLEGR | 66 | Q9Y236 | |
| LEAGEGISDLFDSYD | 416 | Q14209 | |
| QEDYLLSLGEEEGIS | 431 | O00716 | |
| DGNGYIDENELDALL | 201 | P05937 | |
| DLAEEGVLEEAEFYN | 116 | Q9NXV2 | |
| DIDGDGREEIYFLNT | 121 | Q9NQ79 | |
| EDRIIEGGIYDADLN | 26 | P09228 | |
| LEESNEDDYLLGELG | 2886 | P35556 | |
| GGFLLASYDEDSEEL | 776 | P18858 | |
| LQDDLDDYGFEDYGT | 11 | Q9P1A2 | |
| SVLEEYGQDLDQLGE | 141 | Q96JN8 | |
| GETDALDIDYELSFG | 296 | Q8WYK1 | |
| DTEEADIYLLIDGSG | 431 | A6NMZ7 | |
| LDQDLDYLSEGLEGR | 66 | Q9UJX0 | |
| LFDLDVDDGLAAVGY | 411 | Q8IWW8 | |
| LQEDEGSEDASLYGE | 231 | Q8IUW3 | |
| ELDENGDGEVDFQEY | 61 | P23297 | |
| GVYDDGLEELSDALN | 171 | Q96RI8 | |
| EDEEGQDDKDFYLRG | 8306 | Q8NF91 | |
| SDIEDEQLAYGFTEL | 361 | Q1RMZ1 | |
| KDLLGRYFEEEEGQE | 1101 | O94761 | |
| IGDDDELYIVDNNGE | 81 | Q7Z333 | |
| VLASLELQDGEDEGY | 431 | Q9H173 | |
| ELQDGEDEGYFQELL | 436 | Q9H173 | |
| SLYFEDEDGFQELNE | 386 | Q93073 | |
| AGSYLLEELFEGNLE | 41 | P22891 | |
| DDYIAIGADEEELGS | 156 | P23193 | |
| LFEYRNQGDEEGTEI | 121 | O15160 | |
| GGSLDLVSALEDYEE | 141 | B3KU38 | |
| DYAEGELFQILEDDG | 81 | Q9NRP7 | |
| YLGDSGLDDFFLDID | 141 | Q9UJW9 | |
| GDLYLDVAEAFLDVG | 421 | Q9Y5Q9 | |
| EEADEYIDIGALNGI | 1046 | P53396 | |
| EAQDYFLEAQGDLLE | 331 | Q0P6D6 | |
| DDEEEEDGGLLNYLF | 86 | Q9BPX3 | |
| EEEEEDQDYYLGGLR | 126 | Q96A61 | |
| DELLALASIYDGDEF | 11 | Q9UBS8 | |
| VGDEDIYSGLSDQID | 136 | P15498 | |
| DSEEALIYEEDFNGG | 171 | Q9H5I5 | |
| GEIEEDAYQEDLGFS | 381 | Q8WWY3 | |
| YSELDGEEGTEQQLE | 36 | Q9Y6L7 | |
| DLLQEEDFYILDQGG | 276 | O15195 | |
| DDLDRLGVFLDYEAG | 386 | Q14142 | |
| ASEEEGLNFLNEYDE | 1141 | Q9H582 | |
| TDEYDLLDDGGDAVF | 436 | Q9H6S0 | |
| IVSYDDGEEDFVGND | 356 | Q7Z7G8 | |
| QEDAEEYLGFILNGL | 521 | Q14694 | |
| ADYLLGDVEGEEDEL | 536 | Q96S15 | |
| FLDTYQGLLQEEEGA | 226 | Q9UHV5 | |
| YGLNQEEFTDGEEEE | 371 | Q9NRD5 | |
| YDTLGADDLEGEAFL | 1006 | Q70J99 | |
| EIGDGAELTAEFLYD | 296 | Q6IBS0 | |
| LLDEDDYFLNSGDLA | 66 | Q5VZL5 | |
| LYDEELAQGDGADRE | 381 | O95922 | |
| EGEDGLDEIYSFSES | 216 | P13010 | |
| EIDNGDELTADFLYE | 296 | Q12792 |